Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESIcare for Urgency in Overactive Bladder
NCT00454896Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2004
- Primary completion
- Sep 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of solifenacin in overactive bladder syndrome (OAB), sponsored by Astellas Pharma. Started May 2004; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT00454896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454896.